TAT-cyclo-CLLFVY TFA
This cyclic peptide inhibitor disrupts the HIF-1α/HIF-1β heterodimerization with an IC50 of 1.3 μM, effectively blocking hypoxia signaling. It is a valuable research tool for studying hypoxia-driven pathways in cancer biology, applicable in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation, Metabolism Research
Molecular Weight
2673.1
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog